Skip to content
★ Sign in to follow
RF

Rodd Friedman

Arrhythmia Research Technology Inc /DE/
Total declarations
8
Company
1
▲ Purchases (3 ops.)
€279k
▼ Sales (1 ops.)
€69k

Latest filing published 19 Nov 2019 for ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/, €6,784.

Insider track record

Disclosed buys
3
Disclosed sells
1
Signal history

Closed purchases

Market purchases
3
Positive at T+90
0%
Median T+90
-9.1%

Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Rodd Friedman: trading record in brief

Rodd Friedman is a declared insider of Arrhythmia Research Technology Inc /DE/, with filings sourced from SEC (Form 4). Between 16 June 2015 and 18 November 2019, the trades on record add up to 8 filings.

In open-market terms, that means 3 purchases worth €279k on one side and 1 sale worth €69k on the other. Purchases outweigh sales by €210k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 4 share grants.

The median purchase comes to €11k. After 3 purchases with a full 90-day history, the hit rate stands at 0% and the median 90-day move at -9.1%. Past outcomes like these are no guarantee of what comes next.

The record was last updated on 19 November 2019 with a share grant (€6,784) in Arrhythmia Research Technology Inc /DE/. The latest purchase dates back some time: it was published 4,062 days ago, on 25 September 2015. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 25 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Rodd Friedman

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations8 total

8 of 8 declarations